chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received my first Pfizer covid vaccine on 01/30/2021 and second dose 02/20/2021. On 03/13/2021 I begin experiencing muscle twitches initially just in my eyelid and hand then progressed all over my body even internal organs would flutter. It would disrupt sleeping, make tasks difficult and cause anxiety. Twitches peaked in April through May and gradually decreased but remain persist even now, 5 months out. I also had flashes of bright light in my peripheral vision, dizziness and muscle aches in back, neck and extremities with pins and needles sensation. I have seen medical professionals: PCP and neurologists and have had many medical tests performed: labs, CT, X-ray, EMG. All the issues started a few weeks after my 2nd shot and I've been working with medical professionals to resolve it with no real answers or assistance. The medical team could not explain the cause. I'm reporting these adverse side effects to hopefully make things better for others in the future.
Dad had a heart attack either on February 19th or 20th. He was found dead on the morning of February 20th.
On 03/12/2023, shortly after I woke up, I noticed numbness on the left side of my mouth. I observed it for a few hours, but it didn't change. I called my insurance's advice line who advised I be seen at urgent care. By the time I got there, the area had begun to swell. The doctor wasn't sure what was going on. He prescribed an antibiotic and a low dose steroid. He also gave me an anti-virus but advised I don't use it unless I saw evidence. Through the course of the day, the swelling continued to get worse. It went from the left side of my lip into the whole left side of my face. By the end of the day, it started mirroring on the right side. Around 01:00AM ET on 03/13/2023, I looked, and could see that I had a cold sore inside my lip. I had taken two antibiotics and one of the steroids, but once I saw that, I began taking the anti-viral and it has continued to improve.
(R) upper arm - 6 inch diameter - redness, induration, warmth around vaccine site. No tenderness. Area of redness increased to 8 inches on day #2.
pt called to say that had recvd very painful flu shot on 2JAN96 & w/in 24hrs had numbness in the skin between index finger & long finger on lt hand;pt stated hand not painful only skin was numb;took Motrin
Pt presents to office 10/20/06 with blisters type rash around injection site. Hx of fever 102 x 3 days following injection.
Information has been received from a pharmacist concerning a male pt who was vaccinated with a dose of Haemophilus B conjugate vaccine (+) hep B vaccine recombinant. Subsequently the pt developed an "allergic reaction." Unspecified medical attention was sought. Additional info has been requested.
Mild faint erythematous macules on posterior neck and upper trunk that developed several hours after receiving vaccinations.
Extreme pain in left arm, hot and swollen with rash. Cold chills, extremely weak, could barely stand.
PT DEVELOPED STRIDOR AFTER 10 MINS OF RECEIVING VACCINE AND RECEIVED 2 DOSES OF INHALED RACEMIC EPINEPHRINE. SHE RECEIVED 2 DOSES OF 0.3 SUBQ EPINEPHRINE AND THEN SHE GOT SOME SOLU MEDROL 125 MG. PATIENT NOT GETTING ANY BETTER, ANESTHESIA INTUBATED HER. SHE RECEIVED PROPOFOL AND ROCURONIUM. TRANSFERRED TO A HIGHER LEVEL OF CARE.
Patient developed rash, then was hospitalized for six days. Family member said his immune system was affected and therefore his platelet count was way down, but has rebounded and platelet count is approaching normal.
2nd day after final dose woke up with severe vertigo.   Lasted for 5 days.   Since then have had increasing chest discomfort and muscle spasms.  Left shoulder and arm still hurt 2 and a half weeks after dose.
No adverse event; Patient received the bivalent vaccine instead of the monovalent vaccine for second dose of the primary series; This spontaneous case was reported by a medical assistant and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient received the bivalent vaccine instead of the monovalent vaccine for second dose of the primary series) and NO ADVERSE EVENT (No adverse event) in a 27-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 023H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 22-Nov-2022, the patient received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 22-Nov-2022, the patient experienced WRONG PRODUCT ADMINISTERED (Patient received the bivalent vaccine instead of the monovalent vaccine for second dose of the primary series). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient received the bivalent vaccine instead of the monovalent vaccine for second dose of the primary series) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient received the bivalent vaccine instead of the monovalent vaccine for second dose of the primary series).    No concomitant information was reported. The patient received the first dose of the Moderna Covid-19 vaccine on 21-OCT-2022 and lot number 063B22A. It was reported that patient had no other adverse reactions. No treatment information was provided.   This case was linked to MOD-2022-676514 (Patient Link).
Patient report rash on arm, neck, chest; and swelling of eyes and to lesser extent lips. She called her primary care doctor as she lives out of state from where vaccine was received; she was told to use Benadryl, which she did. The Benadryl stopped symptoms from worsening and rash and swelling have improved since they started (unsure of the exact dates)
This spontaneous report was received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. Concurrent conditions and medical history were not provided. Since 23-JUL-2015 and on other unknown dates, an unspecified number of patients were vaccinated with an unspecified number of improperly storage doses of PEDVAXHIB lot # K025006 and expiration date 22-JUL-2017, lot # K026533 and expiration date 07-AUG-2017 and lot # L002867 and expiration date 11-NOV-2017 (dose and route of administration were not provided). There was not concomitant medication reported. The reporter referred that the vaccines were administered by an unspecified physician and no adverse experiences had been reported. Follow up information was received on 25-SEP-2015. All telephone attempts to obtain follow-up information have been unsuccessful. This is one of three reports from the same reporter. Additional information has been requested. Narrative was updated.
Ache; Headache; Fever; Exhaustion/wiped out a day; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Ache), HEADACHE (Headache), PYREXIA (Fever) and FATIGUE (Exhaustion/wiped out a day) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and D(0)13M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (Ache), HEADACHE (Headache), PYREXIA (Fever) and FATIGUE (Exhaustion/wiped out a day). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at a dose of 1 dosage form every six hours. At the time of the report, MYALGIA (Ache), HEADACHE (Headache), PYREXIA (Fever) and FATIGUE (Exhaustion/wiped out a day) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Had shot in morning took Tylenol in the evening. Resolved within a day, took an extra nap, slept for a couple hours.   This case was linked to MOD-2021-379495 (Patient Link).
Patient exprienced muscle aches, weakness and felt lethargic. Symptoms have subsided now without further treatment.
Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/2/2021 and 2/23/2021. Presented to ED on 8/16/2021 with complaints of shortness of breath and productive cough for two weeks. Supplemental oxygen initiated in ED. Medications administered: dexamethasone, ceftriaxone, azithromycin, vancomycin. Patient's chronic renal dysfunction continued to worsen while hospitalized. Patient refused dialysis. After discussion with family discharged home with hospice on 8/25/2021. Per patient's son, patient expired on 8/30/2021 at home.
This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (The vial undergo temperature excursions), EXPIRED PRODUCT ADMINISTERED (Vial was at frozen storage condition at the time of the excursion) and NO ADVERSE EVENT (No adverse event) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B22A and 022C2AA) for COVID-19 prophylaxis. No Medical History information was reported. On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Jul-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (The vial undergo temperature excursions), EXPIRED PRODUCT ADMINISTERED (Vial was at frozen storage condition at the time of the excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (The vial undergo temperature excursions), EXPIRED PRODUCT ADMINISTERED (Vial was at frozen storage condition at the time of the excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (The vial undergo temperature excursions) and EXPIRED PRODUCT ADMINISTERED (Vial was at frozen storage condition at the time of the excursion). Patient had no Allergies reported. Patient did not have any medical history relating to mentioned AE and both Acute and Chronic illnesses at the time of vaccination. Patient was never diagnosed COVID-19 Positive. Patient had not experienced similar event in the past. No other vaccine was administered 1 month prior to Moderna vaccine. No concomitant medications were reported. It was reported that the temperature excursions started from the day vaccines were received on 24-Jun-2022 until 24-Aug-2022 because the freezer was not acceptable, there were no details at what temperature the vials were kept due to unavailability. Total 4 doses were administered out of 100 doses. Administered dose out of a 100 doses past the 30 day use by date. The vial was never stored in the refrigerator. Vial did undergo Temperature Excursions, including the storage condition at the time of the excursion was Frozen storage. The vial was never moved from freezer to refrigerator. Vials were then stored in the Freezer. There was no visual inspection noted on vaccine state change. Total 96 doses were impacted. Total one vial was punctured and discarded. No treatment details were reported.
17 year old female received Pfizer COVID vaccine and was told to sit and wait 15 minutes for monitoring after the shot. Patient attempted to leave before the time elapsed with her father and collapsed in the aisle. She was able to be assisted to a nearby chair and 911 was called. I was told she did not hit her head or any other part of her body when she fell. I attempted to take her blood pressure, but it was too low. Patient appeared very pale and was responsive but stated she was seeing black and couldn't hear properly. She did not eat anything that morning. Patient continued to talk and answer questions updating me on her improvements but still appeared very lethargic and eyes were not focused. EMTs arrived and her BP was 81/46. EMTs, store management and health care ambassador remained with patient. Patient began to feel better and did not go to the hospital. EMTs left and management and associate remained with patient. Once patient felt better, she walked out of the pharmacy/store with her father.
Administration of an expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration of an expired vaccine) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration of an expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administration of an expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was reported  No treatment medication information was reported
Tingling in all extremities followed by hot flash and then tachycardia.  Heart rate ~150?s. Signs/symptoms started about 3 mins after injection and lasted around 10-15 mins.
Pt had adverse reaction to 1st SHINGRIX. She said staff injected shot more towards the back side of the deltoid rather than right in the middle of the deltoid. She said he must have hit a nerve in her left arm because lifting her arm is painful. The pain started a couple days after she received the shot. The pain traveled from shoulder down to elbow. Pt states it is better now but still painful.
Given the shot at approx. 3:45 p.m. on Monday, October 28.  By 7:00 p.m., I noticed that my arm was very sore and itching around the site where I'd had the shot.  Upon examination, I noticed that my whole upper arm was red to the elbow and my entire arm was swollen to my wrist.  I called my sister-in-law who is a neurosurgical nurse, who suggested that I take Tylenol and put an ice pack on the site.  I sent my husband to the store to buy Benadryl, which I took around 8:30 and then again at 12:30 a.m.  The next morning, my arm was swollen, sore, and red again, so I took the Benadryl and Tylenol again, taking every 4 hours the next day.  I called the Health Dept and talked to someone in immunizations who basically did not seem concerned at the reaction I'd had.  She thought it sounded like a latex allergy and said since it seemed better, that it would probably be ok.  I reminded her that I was only better because I was taking Tylenol and Benadryl every 4 hours.  By Wednesday, I noticed that the site was reduced to a quarter sized red spot of inflammation around the injection site.  This remained through Thursday.
Dizziness occurring approximately 4 hours after receiving vaccine.  Patient presented back to vaccine clinic.  Blood pressure lower than patient's reported normal blood pressure.   Close monitoring by nurse.  Blood pressure increased during monitoring period.
Left deltoid swollen, hard and warm to the touch. 9 x 10 cm on 10-27-16 morning. Increased size of Rx by afternoon.
dizzy/woozy; nausea; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (sore arm), DIZZINESS (dizzy/woozy) and NAUSEA (nausea) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PAIN (sore arm). On 02-Feb-2021, the patient experienced DIZZINESS (dizzy/woozy) and NAUSEA (nausea). On 21-Jan-2021, PAIN (sore arm) had resolved. At the time of the report, DIZZINESS (dizzy/woozy) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.    Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: TCR on 25-MAY-2021 and does not contain any new information
R arm indurated, erythematous, painful, hot. Cellulitis vs Severe local reaction. TX: KEFLEX, BENADRYL, MOTRIN, ice.
This case was reported by a healthcare professional via sales representative and described the occurrence of death (cause unknown) in a male subject of unspecified age who was vaccinated with FLULAVAL (GlaxoSmithKline). On an unspecified date in 2013 the subject received a dose of FLULAVAL (unknown). In 2013, 2 months after vaccination with FLULAVAL, the subject experienced death (cause unknown). The subject died on an unspecified date in 2013, cause of death was not unknown. It was unknown whether an autopsy was performed.
Heart pain (experienced a sharp pain with each heart beat ) beginning about 15 hrs after receiving the shot. This pain continued for around 6 to 8 hrs.
High fever~ 102 degrees F Swelling of arm~ about the size of a softball Fever lasted for two days and swelling lasted for a week.
Tired; Huge purple birth mark with a lump; Had a scratchy throat; Huge purple birth mark with a lump; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tired), VACCINATION SITE BRUISING (Huge purple birth mark with a lump), THROAT IRRITATION (Had a scratchy throat) and VACCINATION SITE MASS (Huge purple birth mark with a lump) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced FATIGUE (Tired), VACCINATION SITE BRUISING (Huge purple birth mark with a lump), THROAT IRRITATION (Had a scratchy throat) and VACCINATION SITE MASS (Huge purple birth mark with a lump). At the time of the report, FATIGUE (Tired), VACCINATION SITE BRUISING (Huge purple birth mark with a lump), THROAT IRRITATION (Had a scratchy throat) and VACCINATION SITE MASS (Huge purple birth mark with a lump) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported.    This case was linked to MOD-2021-057778 (Patient Link).
Pt became ash grey, skin ice cold, didn't move for about 4 hrs, body more stiff than usual, refused to suck, did not cry or make any noise;
This case was reported by a nurse and described a 7-year-old female subject who was inadvertently vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix, GlaxoSmithKline) for prophylaxis. There were no concurrent medications. On 26 July 2006, the subject inadvertently received an unspecified 0.5 ml dose of Infanrix (lot number AC14B027AA) rather than the intended administration of tetanus and diphtheria toxoid). Site of administration was left arm. Infanrix is not recommended fro immunizing individuals 7 years of age or older. concurrent vaccinations given on the same date included hepatitis B vaccine (manufacturer unknown), injection of poliomyelitis virus vaccine (IPOL, Aventis Pasteur) and measles, mumps and rubella vaccine (manufacturer known).
Patient with a history of left frontal WHO grade 3 anaplastic oligodendroglioma, status post resection and radiation in 2019, then redo surgery May 2021 for enlarging recurrent left frontal enhancing mass with cerebral edema.  Per wife, had increasing weakness at home and arranged Inpatient rehab stay. While there, was not progressing as expected and had imaging that showed recurrence of cerebral edema, same site of both prior recurrences. Sent here to our ED as both prior operations with physician. He is slow to respond and initially said he was in a different location, but reorients and pleasant otherwise. He also follows with another physician and is currently on timozolomide (chemo). Fidgeting with his glasses and needs redirected frequently. Has low grade temp but on room air and no cough. Says he had his third COVID shot about a month ago. No known exposures but has been at rehab facility. Has no symptoms otherwise, but tested COVID positive here.   PT CONTINUES TO BE INPATIENT AT THIS TIME.
Child had a set of vaccines on 7/25/12. He awoke the next day with fever, rash, vomiting, diarrhea. He was seen in the ER on 7/29/12 and had a follow up visit with PCP on 7/30/12 and was then admitted to the hospital with acute gastroenteritis, dehydration, fever "likely from a viral syndrome and thrombocytopenia" according to the hospital D/C summary.
I had a call in the pharmacy today (sunday 25th), stating pt has a large redness and mild pain...initially she had swelling and it subsided.
I had immediate headache after the vaccine and felt tightness in the neck. I waited 30+ minutes at the vaccine site and was tested by EMT professionals twice. After they approved me to go I left the site. Had persistent headache, fever, body ache. Next 2 days had visual and auditory hallucinations.
Noticed late on 9/1/2022, her right arm (injection site) was swollen, itchy, hot, bruised and had a welt.
pt devel fever w/circular indurated rash 6cm around inj site, hives, few 1 day p/vax;rash 2 days p/vax; myalgia;resolved by day 5;ATB given doubt was cellulitis;also put on Claritin;